Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
MEDICINAL PRODUCT
Document Type and Number:
WIPO Patent Application WO/2020/138407
Kind Code:
A1
Abstract:
Provided is a technique for suppressing the change in blending between pemafibrate or a salt of pemafibrate or a solvate of pemafibrate or the salt and a (meth)acrylic acid-based polymer. A medicinal product comprising: an air-tight packaging material; and a pharmaceutical composition which is included in the air-tight packaging material and comprises (A) pemafibrate or a salt of pemafibrate or a solvate of pemafibrate or the salt and (B) a (meth)acrylic acid-based polymer.

Inventors:
NISHIDA CHISA (JP)
Application Number:
PCT/JP2019/051390
Publication Date:
July 02, 2020
Filing Date:
December 27, 2019
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
KOWA CO (JP)
International Classes:
A61K31/423; A61K9/14; A61K9/16; A61K9/20; A61K9/48; A61K47/32; A61P1/16; A61P3/06
Domestic Patent References:
WO2005023777A12005-03-17
WO2019004448A12019-01-03
WO2019004453A12019-01-03
WO2019004452A12019-01-03
WO2019004451A12019-01-03
WO2019004450A12019-01-03
Foreign References:
US7109226B22006-09-19
Other References:
ANONYMOUS: "Report on the deliberation results of parmodia tablets 0.1 mg [Common name: pemafibrate]", PMDA REPORT ON THE DELIBERATION RESULTS, 3 July 2017 (2017-07-03), pages 1 - 74, XP009518270
FRUCHART JC., CARDIOVASC DIABETOL, vol. 12, 2013, pages 82
"Handbook of Pharmaceutical Excipients", PHARMACEUTICAL PRESS
Attorney, Agent or Firm:
THE PATENT CORPORATE BODY ARUGA PATENT OFFICE (JP)
Download PDF: